622 related articles for article (PubMed ID: 33574984)
1. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
2. miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.
Hu X; Liu H; Wang Z; Hu Z; Li L
Oxid Med Cell Longev; 2019; 2019():1512326. PubMed ID: 31781322
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
4. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
6. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
Fan D; Chen HB; Leng Y; Yang SJ
Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
[TBL] [Abstract][Full Text] [Related]
7. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
8. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
[TBL] [Abstract][Full Text] [Related]
9. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TRIM16 mitigates doxorubicin-induced cardiotoxicity by modulating TAK1 and YAP/Nrf2 pathways in mice.
Guo X; Liu M; Han B; Zheng Y; Zhang K; Bao G; Gao C; Shi H; Sun Q; Zhao Z
Biochem Pharmacol; 2024 Feb; 220():116009. PubMed ID: 38154547
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
12. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
13. Galangin attenuates doxorubicin-induced cardiotoxicity via activating nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Yang Y; Lan C
Phytother Res; 2023 Dec; 37(12):5854-5870. PubMed ID: 37655750
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
15. Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2.
Zhao Y; Sun J; Zhang W; Peng M; Chen J; Zheng L; Zhang X; Yang H; Liu Y
Oxid Med Cell Longev; 2020; 2020():3598715. PubMed ID: 32831995
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
[No Abstract] [Full Text] [Related]
19. MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1.
Xu C; Liu CH; Zhang DL
Biochem Biophys Res Commun; 2020 Jan; 521(2):485-491. PubMed ID: 31677784
[TBL] [Abstract][Full Text] [Related]
20. Protective Effects of
Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
